Robert M. Langlinais, Jr.
Owner and CEO
Langlinais’ Baking Company
814 West Congress St.
Lafayette , LA 70501
United StatesFEI 3004690548Issued Mar 14, 2022Office of Human and Animal Foods Operations-East
Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3004690548.
Violations4
Issue DateMar 14, 2022
Product TypeFood & Beverages
StatusClosed
Closeout LetterMay 15, 2023
Letter Details
Firm
Langlinais’ Baking Company
Location
Robert M. Langlinais, Jr.
Owner and CEO
Langlinais’ Baking Company
814 West Congress St.
Lafayette , LA 70501
United States
FEI Number
3004690548
Country
United States
Issue Date
March 14, 2022
Issuing Office
Office of Human and Animal Foods Operations-East
Product Type
Food & Beverages
Status
Closed
Closeout Letter
May 15, 2023
Summary
Langlinais' Baking Company, a ready-to-eat bakery in Lafayette, Louisiana, manufactured breads and rolls under insanitary conditions that posed contamination and health risks, violating Current Good Manufacturing Practice (CGMP) and Hazard Analysis and Risk-Based Preventive Controls requirements under 21 CFR Part 117. FDA investigators found during a November 2021 inspection that the company failed to conduct adequate hazard analysis for its RTE products to identify known or reasonably foreseeable hazards requiring preventive controls. The facility's products were determined to be adulterated because they were prepared, packed, or held under conditions whereby they may have become contaminated with filth or rendered injurious to health. As of the March 2022 warning letter issuance, the company had not responded to the FDA Form 483 inspectional observations issued at the conclusion of the inspection.
Langlinais’ Baking Company FDA Warning Letter, March 14, 2022